Each week, The American Journal of Managed Care® recaps the highest managed care information of the week, and now you can hearken to it on our podcast, Managed Care Forged.
This week, the highest managed care information included FDA advising towards modifications to vaccine dose schedules; drop in mammography screenings in the course of the first months of the pandemic; first anti-TIGIT remedy granted Breakthrough Remedy designation by the FDA.
Hear above or by one in all these podcast providers:
Learn extra in regards to the tales on this podcast:
Mammography Screenings Dropped, Advanced Breast Cancer Cases Increased in First Months of COVID-19
FDA Grants Tiragolumab Breakthrough Therapy Designation for PD-L1–High NSCLC
Azacitidine Shown to Improve Overall, Relapse-Free Survival in Older Adults With AML
